Esmolol is named as a drug or biological intervention in 3 clinical trials in our China trial register, 1 of which is recruiting. Lead sponsors include First Affiliated Hospital of Wannan Medical College (1), Qianfoshan Hospital (1) and Yongtao Sun (1). Registered phases: Phase 4 and Not applicable. Conditions studied include Septic Shock; Sepsis; Critical Illness Sepsis, Severe.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT05635877 | Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients (ClinicalTrials.gov ↗) Frailty, Esmolol, Myocardial Injury |
Phase 4 | Recruiting |
| NCT06958393 | Effect of Opioid-free Anaesthesia on Postoperative Delirium in Elderly Patients Undergoing Gastrointestinal Surgery (ClinicalTrials.gov ↗) Delirium - Postoperative, Opioid-Free Anaesthesia |
Phase 4 | Not yet open |
| NCT07657754 | Effects of Esmolol on Sublingual Microcirculation and Vascular Waterfall Phenomenon in Patients With Septic Shock (ClinicalTrials.gov ↗) Septic Shock, Sepsis, Critical Illness Sepsis, Severe |
Not applicable | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Septic Shock | 1 |
| Sepsis | 1 |
| Critical Illness Sepsis, Severe | 1 |
| Delirium - Postoperative | 1 |
| Opioid-Free Anaesthesia | 1 |
| Frailty | 1 |
| Esmolol | 1 |
| Myocardial Injury | 1 |
| Lead sponsor | Trials |
|---|---|
| First Affiliated Hospital of Wannan Medical College | 1 |
| Qianfoshan Hospital | 1 |
| Yongtao Sun | 1 |
| Register | Esmolol trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Esmolol works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Esmolol (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.